Skip to main content
Erschienen in: Intensive Care Medicine 9/2013

01.09.2013 | Statistical Note

How to interpret a randomized controlled study stopped early

verfasst von: G. Leandro

Erschienen in: Intensive Care Medicine | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Excerpt

This issue of Intensive Care Medicine publishes data from a multicenter randomized controlled trial (RCT) by Joannes-Boyau et al. [1] on high-volume versus standard-volume hemofiltration for septic shock patients with acute kidney injury. The study was stopped early because of the authors’ inability to recruit and enroll all planned participants, therefore calling into question how to interpret lower than the expected volume of data, which is a problem that occurs frequently in RCTs [2]. …
Literatur
1.
Zurück zum Zitat Joannes-Boyau O, Honoré P, Perez P et al (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicenter randomized controlled trial. Intens Care Med. doi:10.1007/s00134-013-2967-z Joannes-Boyau O, Honoré P, Perez P et al (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicenter randomized controlled trial. Intens Care Med. doi:10.​1007/​s00134-013-2967-z
2.
Zurück zum Zitat Friedlin B, Korn EL (2009) Stopping clinical trials early for benefit: impact on estimation. Clin Trials 6:119–125CrossRef Friedlin B, Korn EL (2009) Stopping clinical trials early for benefit: impact on estimation. Clin Trials 6:119–125CrossRef
3.
Zurück zum Zitat Sargent D (2009) Early stopping for benefit in National Cancer Institute-sponsored phase III trials: the system is working. J Clin Oncol 27(10):1543–1544PubMedCrossRef Sargent D (2009) Early stopping for benefit in National Cancer Institute-sponsored phase III trials: the system is working. J Clin Oncol 27(10):1543–1544PubMedCrossRef
4.
Zurück zum Zitat Korn EL, Friedlin B, Mooney M (2009) Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute cooperative group experience from 1990 to 2005. J Clin Oncol 27(10):1712–1721PubMedCrossRef Korn EL, Friedlin B, Mooney M (2009) Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute cooperative group experience from 1990 to 2005. J Clin Oncol 27(10):1712–1721PubMedCrossRef
5.
Zurück zum Zitat Montori VM, Devereaux PJ, Adhikari NKJ et al (2005) Randomized trials stopped early for benefit. A systematic review. JAMA 294(17):2203–2209PubMedCrossRef Montori VM, Devereaux PJ, Adhikari NKJ et al (2005) Randomized trials stopped early for benefit. A systematic review. JAMA 294(17):2203–2209PubMedCrossRef
6.
Zurück zum Zitat Berry SM, Carlin BP, Connor J (2010) Bias and trials stopped early for benefit. Letters to the Editor. JAMA 304(2):156–159 Berry SM, Carlin BP, Connor J (2010) Bias and trials stopped early for benefit. Letters to the Editor. JAMA 304(2):156–159
7.
Zurück zum Zitat Ware JH, Muller JE, Braunwald E (1985) The futility index. An approach to cost-effective termination of randomized clinical trials. Am J Med 78(4):635–643PubMedCrossRef Ware JH, Muller JE, Braunwald E (1985) The futility index. An approach to cost-effective termination of randomized clinical trials. Am J Med 78(4):635–643PubMedCrossRef
8.
Zurück zum Zitat DeMets DL (2006) Futility approaches to interim monitoring by data monitoring committees. Clin Trial 3:522–529CrossRef DeMets DL (2006) Futility approaches to interim monitoring by data monitoring committees. Clin Trial 3:522–529CrossRef
Metadaten
Titel
How to interpret a randomized controlled study stopped early
verfasst von
G. Leandro
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 9/2013
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-013-3000-2

Weitere Artikel der Ausgabe 9/2013

Intensive Care Medicine 9/2013 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.